Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 2
1953 1
1954 1
1956 1
1957 1
1958 1
1960 1
1962 1
1963 2
1967 1
1970 1
1971 3
1972 1
1973 3
1974 2
1975 2
1976 5
1977 3
1978 4
1983 1
1985 1
1986 1
1988 1
1989 1
1994 1
1995 3
1998 1
2000 2
2001 1
2002 2
2003 2
2004 1
2005 3
2006 2
2007 5
2008 8
2009 6
2010 6
2011 7
2012 12
2013 6
2014 6
2015 7
2016 9
2017 2
2018 2
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Hacke W, et al. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656. N Engl J Med. 2008. PMID: 18815396 Free article. Clinical Trial.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group; Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Lees KR, et al. Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6. Lancet. 2010. PMID: 20472172
Hypertension, brain damage and cognitive decline.
Gąsecki D, Kwarciany M, Nyka W, Narkiewicz K. Gąsecki D, et al. Among authors: nyka w. Curr Hypertens Rep. 2013 Dec;15(6):547-58. doi: 10.1007/s11906-013-0398-4. Curr Hypertens Rep. 2013. PMID: 24146223 Free PMC article. Review.
Renal Dysfunction in Post-Stroke Patients.
Chwojnicki K, Król E, Wierucki Ł, Kozera G, Sobolewski P, Nyka WM, Zdrojewski T. Chwojnicki K, et al. Among authors: nyka wm. PLoS One. 2016 Aug 30;11(8):e0159775. doi: 10.1371/journal.pone.0159775. eCollection 2016. PLoS One. 2016. PMID: 27575370 Free PMC article.
Neuropsychological assessment in myasthenia gravis.
Sitek EJ, Bilińska MM, Wieczorek D, Nyka WM. Sitek EJ, et al. Among authors: nyka wm. Neurol Sci. 2009 Feb;30(1):9-14. doi: 10.1007/s10072-008-0001-y. Epub 2009 Jan 16. Neurol Sci. 2009. PMID: 19148573
[Diagnostic difficulties in myasthenia gravis].
Bilińska M, Nyka WM. Bilińska M, et al. Among authors: nyka wm. Pol Merkur Lekarski. 2011 Apr;30(178):277-82. Pol Merkur Lekarski. 2011. PMID: 21595175 Review. Polish.
127 results